Join us for Insmed’s bronchiectasis programming at the ATS 2024 International Conference
Insmed is excited to present information about bronchiectasis at this year’s conference as part of our goal to increase awareness of the disease and the impact of bronchiectasis exacerbations.
Clinical and patient-centered discussions on the role of inflammation in bronchiectasis
Colin Swenson, MDSection Chief, Pulmonary and Critical CareDirector, NCFB/NTM ProgramEmory Healthcare
George M Solomon, MDUAB Division of Pulmonary, Allergy, and Critical Care MedicineDirector, UAB Adult PCD and Bronchiectasis ProgramsUniversity of Alabama at Birmingham
11:30 a.m. PT, Sunday, May 19
Innovation Theater 5An Innovation Theater presentation at the ATS 2024 International Conference
During this expert-led session, participants will review the burdens and underlying causes of bronchiectasis exacerbations, with a focus on current management strategies. This discussion will also delve into the key drivers of bronchiectasis, including the critical role of inflammation.
Lunch will be provided.
Want to keep up with bronchiectasis research and information?
